All In Biotech

Drug Trial Radar · NCT06360796

Study of Pharmacokinetics and Metabolism on [(14)C]ADC189

A Phase I Study to Investigate the Absorption, Metabolism, Excretion, and Safety of [(14)C]ADC189 in Healthy Chinese Male Volunteers

Last checked: Nov 19, 2026Latest source record: Jan 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

6

Actual

Start

Nov 24, 2023

Primary completion

Feb 20, 2024

Study completion Feb 20, 2024

Sponsor

Sponsor type
Industry
First posted
Apr 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to determined the metabolism, excretion, and substance balance of almonertinib of ADC189. The pharmacokinetic characteristics and safety profile of ADC189 was investigated following a single oral dose (45 mg/100 µCi) in healthy Chinese male participants.

Conditions

  • Pharmacokinetics
  • Metabolism

Interventions

  • [(14)C]ADC189Drug

    Each subject take a single oral dose of about 45 mg (about 100 μCi) \[(14)C\]ADC189 on Day 1 of the study, and be observed by 504 hours.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Area Under the Curve (AUC) of [(14)C]ADC189 and its metabolitesTime frame: 504 hours
  2. The Maximum Plasma Concentration [Cmax] of [(14)C]ADC189 and its metabolitesTime frame: 504 hours
  3. The whole blood and serum concentrations of total radioactivity of [(14)C]ADC189 (about 100 μCi)Time frame: 504 hours
  4. The urinary and fecal recovery of total radioactivity of [(14)C]ADC189 (about 100 μCi)Time frame: 504 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affilicated Hospital of Bengbu Medical University

    Bengbu, Anhui, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.